p53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection

This publication has 63 references indexed in Scilit:

• Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis
  World Journal of Gastroenterology, 2001
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Is the p53 Gene Mutation of Prognostic Value in Hepatocellular Carcinoma After Resection?
  Archives of Surgery, 2000
• p53 NUCLEAR ACCUMULATION IS NOT ASSOCIATED WITH DECREASED DISEASE-FREE SURVIVAL IN PATIENTS WITH NODE POSITIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER
  Journal of Urology, 2000
• p53 ACCUMULATION ASSOCIATED WITH bcl-2, THE PROLIFERATION MARKER MIB-1 AND SURVIVAL IN PATIENTS WITH PROSTATE CANCER SUBJECTED TO WATCHFUL WAITING
  Journal of Urology, 2000
• Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma.
  International Journal of Molecular Medicine, 2000
• OUTCOME PREDICTION WITH p53 IMMUNOSTAINING AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
  Journal of Urology, 2000
• The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma
  Cancer, 2000
• TP53Mutation is an Independent Prognostic Marker for Poor Outcome in Both Node-negative and Node-positive Breast Cancer
  Acta Oncologica, 2000
• The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas
  Surgery Today, 1999